In primary human RCC cells (“RCC1/RCC2/RCC3”), treatment with SC66 induced apoptosis activation, as evidenced by a significant increase in nuclear TUNEL staining (Fig. 2f). This evidence concerns the gene RCC2 and renal cell carcinoma.